Cita APA (7a ed.)
Johnston, A. N., Bu, W., Hein, S., Garcia, S., Camacho, L., Xue, L., . . . Li, Y. (2018). Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Research, 20(1), -1.
Cita Chicago Style (17a ed.)
Johnston, A. N., et al. "Hyperprolactinemia-inducing Antipsychotics Increase Breast Cancer Risk by Activating JAK-STAT5 in Precancerous Lesions." Breast Cancer Research 20, no. 1 (2018): -1.
Cita MLA (9a ed.)
Johnston, A. N., et al. "Hyperprolactinemia-inducing Antipsychotics Increase Breast Cancer Risk by Activating JAK-STAT5 in Precancerous Lesions." Breast Cancer Research, vol. 20, no. 1, 2018, pp. -1.
Precaución: Estas citas no son 100% exactas.